VAX1 and coloboma: Both in this patient and in the Vax2-null mouse, the phenotype is mild compared to that associated both with a previously reported human VAX1 mutation and a targeted murine Vax1 deletion, where coloboma was fully penetrant and moderately severe [13, 14].